The identification of cell surface antigens is critical to the development of new diagnostic and
therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (…

The recently identified PTEN/MMAC1 gene is a candidate tumor suppressor implicated in
multiple tumor types based on mutations or homozygous deletions of the gene in certain …

Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

While mutations affecting protein-coding regions have been examined across many cancers,
structural variants at the genome-wide level are still poorly defined. Through integrative …

… Author contributions: Robert E. Reiter had full access to all the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data analysis. …

Prostate cancer mortality results from metastasis to bone and hormone-independent tumor
growth. Models to study these progressive changes are lacking. Here we describe the …

Background Conventional biopsy fails to detect the presence of some prostate cancers (PCas).
Men with a prior negative biopsy but persistently elevated prostate-specific antigen (PSA) …

BACKGROUND The current study was conducted to evaluate the performance of magnetic
resonance (MR)‐ultrasound‐guided fusion biopsy in diagnosing clinically significant prostate …

The transition from androgen-dependent to castration-resistant prostate cancer (CRPC) is a
lethal event of uncertain molecular etiology. Comparing gene expression in isogenic …

Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …